← Russell 3000 cross-section

GRDN Guardian Pharmacy Services, Inc.

Trailing twelve months to 2026-06-30 · as filed 2026-08-06, not restated
Consumer Disc

Scale

Market cap
$2.4bn
Revenue TTM
$1.5bn
Net income TTM
$66m
Free cash flow
Composite score
58.0
Sector rank
#1545

Valuation

P / E
35.8
EV / EBITDA
20.9
EV / sales
1.6
FCF yield
Earnings yield vs 10-yr
-1.94pp

Earnings yield vs 10-yr compares what the business earns per pound invested against the 4.73% a 10-year US Treasury note pays for no equity risk. Negative means you are paying up front for growth not yet delivered.

Quality and growth

Net margin
4.5%
EBITDA margin
7.4%
ROE
25.6%
ROIC
50.9%
Revenue growth
10.3%

Insider activity, last 90 days

Net open-market
$0.00m
Buyers
0
Sellers
0

Open-market purchases and sales only. Grants, option exercises, gifts and shares withheld for tax are excluded: they are how people are paid, not what they think.

What management said

Total consideration for the 2025 Acquisitions included $ 13,725 of cash, $ 125 of deferred inventory payments, 24,075 shares of Class B common stock with a fair value of $ 441 , and contingent earnout payments of up to $ 2,600 if certain revenue and earnings targets are achieved by certain acquired 10 entities during the first full four quarters subsequent to the acquisition date. Basic earnings per share of Class A and Class B common stock is computed by dividing net income attributable to Guardian Pharmacy Services, Inc. by the weighted-average number of shares of Class A and Class B common stock outstanding during the period. …Guardian Pharmacy Services, Inc., 10-Q, period ended 2026-06-30, filed 2026-08-06

Read the full passage →